Share on StockTwits

GMP Securities started coverage on shares of Concordia Healthcare Corp. (TSE:CXR) in a research note issued on Wednesday. The firm set a “buy” rating on the stock.

Separately, analysts at TD Securities initiated coverage on shares of Concordia Healthcare Corp. in a research note on Thursday, May 1st. They set a “buy” rating and a C$34.00 price target on the stock.

Concordia Healthcare Corp. (TSE:CXR) traded up 0.06% on Wednesday, hitting $31.71. The stock had a trading volume of 533,283 shares. Concordia Healthcare Corp. has a 52-week low of $0.481 and a 52-week high of $31.80. The stock has a 50-day moving average of $26.13 and a 200-day moving average of $17.86. The company has a P/E ratio of 81.26.

Concordia Healthcare Corp., formerly Mercari Acquisition Corp., is an integrated, specialty healthcare company focused on the acquisition of pharmaceutical products and medical devices and the acquisition and/or development of orphan drugs.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.